In the normal course of the delivery of care, anesthesiologists encounter many patients who
are receiving drugs that affect platelet function as a fundamental part of primary and …

BACKGROUND: The absolute risk of recurrences among patients using aspirin for
prevention of cardiovascular events remains high. Persistent platelet reactivity despite …

Background Population studies suggest that persons with diabetes are more sensitive to the
effects of particulate matter (PM) air pollution. However, the biological mechanisms of a …

It was the aim of the present study to perform a systematic review of the published studies
that estimated the prevalence of non-responders to aspirin, as assessed by the closure time …

Atherothrombosis, characterized by atherosclerotic plaque rupture and subsequent
occlusive or subocclusive thrombus formation is the primary cause of acute ischemic …

The efficacy with aspirin and clopidogrel treatment has been demonstrated in various
clinical trials. Laboratory evaluation of platelet response in recent studies revealed that a …

INTRODUCTION: Diabetes is known to be a prothrombotic state. Since serotonin uptake
plays a role in both platelet activation and depression, we undertook to examine a …

Aspirin is effective for the prevention of cardiovascular events in patients with a history of
vascular disease, as so-called secondary prevention. In general populations with no history …

Background Randomized controlled trials have shown that≤ 100 mg aspirin daily is not
effective for primary prevention of cardiovascular events in diabetes; however, clinical and …

Diabetes mellitus is commonly associated with both microvascular and macrovascular
complications (coronary artery disease, cerebrovascular events, severe peripheral vascular …